BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2142379)

  • 1. MR imaging of the postoperative lumbar spine: assessment with gadopentetate dimeglumine.
    Ross JS; Masaryk TJ; Schrader M; Gentili A; Bohlman H; Modic MT
    AJNR Am J Neuroradiol; 1990; 11(4):771-6. PubMed ID: 2142379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR imaging of the postoperative lumbar spine: assessment with gadopentetate dimeglumine.
    Ross JS; Masaryk TJ; Schrader M; Gentili A; Bohlman H; Modic MT
    AJR Am J Roentgenol; 1990 Oct; 155(4):867-72. PubMed ID: 2119123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadopentetate dimeglumine-enhanced MR imaging of the postoperative lumbar spine: comparison of fat-suppressed and conventional T1-weighted images.
    Mirowitz SA; Shady KL
    AJR Am J Roentgenol; 1992 Aug; 159(2):385-9. PubMed ID: 1632362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lumbar spine: postoperative MR imaging with Gd-DTPA.
    Hueftle MG; Modic MT; Ross JS; Masaryk TJ; Carter JR; Wilber RG; Bohlman HH; Steinberg PM; Delamarter RB
    Radiology; 1988 Jun; 167(3):817-24. PubMed ID: 2966418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign lumbar arachnoiditis: MR imaging with gadopentetate dimeglumine.
    Johnson CE; Sze G
    AJNR Am J Neuroradiol; 1990; 11(4):763-70. PubMed ID: 2114765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR imaging of Sturge-Weber syndrome: role of gadopentetate dimeglumine and gradient-echo techniques.
    Elster AD; Chen MY
    AJNR Am J Neuroradiol; 1990; 11(4):685-9. PubMed ID: 2114749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR imaging of spondylitis with gadopentetate dimeglumine enhancement.
    Demaerel P; van Ongeval C; Wilms G; Lateur L; Baert AL
    J Neuroradiol; 1994 Dec; 21(4):245-54. PubMed ID: 7884486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadopentetate-dimeglumine-enhanced MR imaging of gliomatosis cerebri: appearance mimicking leptomeningeal tumor dissemination.
    Rippe DJ; Boyko OB; Fuller GN; Friedman HS; Oakes WJ; Schold SC
    AJNR Am J Neuroradiol; 1990; 11(4):800-1. PubMed ID: 2114771
    [No Abstract]   [Full Text] [Related]  

  • 9. MR imaging of optic nerve lesions: value of gadopentetate dimeglumine and fat-suppression technique.
    Hendrix LE; Kneeland JB; Haughton VM; Daniels DL; Szumowski J; Williams AL; Mark LP; Czervionke LF
    AJNR Am J Neuroradiol; 1990; 11(4):749-54. PubMed ID: 2114763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of renal artery stenosis: feasibility of combining MR angiography, MR renography, and gadopentetate-based measurements of glomerular filtration rate.
    Ros PR; Gauger J; Stoupis C; Burton SS; Mao J; Wilcox C; Rosenberg EB; Briggs RW
    AJR Am J Roentgenol; 1995 Dec; 165(6):1447-51. PubMed ID: 7484583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rectal carcinoma: prospective comparison of conventional and gadopentetate dimeglumine enhanced fat-suppressed MR imaging.
    Okizuka H; Sugimura K; Yoshizako T; Kaji Y; Wada A
    J Magn Reson Imaging; 1996; 6(3):465-71. PubMed ID: 8724412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadopentetate dimeglumine-enhanced MR imaging of the musculoskeletal system.
    Beltran J; Chandnani V; McGhee RA; Kursunoglu-Brahme S
    AJR Am J Roentgenol; 1991 Mar; 156(3):457-66. PubMed ID: 1899738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital subtraction in contrast-enhanced MR imaging of the postoperative lumbar spine.
    Murray JG; Stack JP; Ennis JT; Behan M
    AJR Am J Roentgenol; 1994 Apr; 162(4):893-8. PubMed ID: 8141014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadopentetate dimeglumine-enhanced MR of the brain: clinical utility and safety in patients younger than two years of age.
    Eldevik OP; Brunberg JA
    AJNR Am J Neuroradiol; 1994 Jun; 15(6):1001-8. PubMed ID: 8073967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadopentetate dimeglumine: observations on the clinical research process.
    Kieffer SA
    Radiology; 1990 Jan; 174(1):7-8. PubMed ID: 2403685
    [No Abstract]   [Full Text] [Related]  

  • 16. Gadolinium-enhanced MR imaging in the management of a midline cerebral dysgerminoma.
    Hawes DR; Yuh WT; Wen BC
    Comput Med Imaging Graph; 1989; 13(6):463-8. PubMed ID: 2598155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lumbosacral spine: early and delayed MR imaging after administration of an expanded dose of gadopentetate dimeglumine in healthy, asymptomatic subjects.
    Jinkins JR; Rauch RA; Gee GT; Bazan C; Xiong L; Kashanian FK; Hanna EP
    Radiology; 1995 Oct; 197(1):247-51. PubMed ID: 7568831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary adenomas and normal pituitary tissue: enhancement patterns on gadopentetate-enhanced MR imaging.
    Miki Y; Matsuo M; Nishizawa S; Kuroda Y; Keyaki A; Makita Y; Kawamura J
    Radiology; 1990 Oct; 177(1):35-8. PubMed ID: 2399335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR arthrography of the shoulder with gadopentetate dimeglumine: influence of concentration, iodinated contrast material, and time on signal intensity.
    Kopka L; Funke M; Fischer U; Keating D; Oestmann J; Grabbe E
    AJR Am J Roentgenol; 1994 Sep; 163(3):621-3. PubMed ID: 8079856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing brain MR imaging protocols with gadopentetate dimeglumine: enhancement of intracranial lesions on spin-density- and T2-weighted images.
    Wessbecher FW; Maravilla KR; Dalley RW
    AJNR Am J Neuroradiol; 1991; 12(4):675-9. PubMed ID: 1882743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.